Sign in
TerminatedNo phase

Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease

Key facts

Who runs it
Insel Gruppe AG, University Hospital Bern
Where
Switzerland4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
10 people enrolled
Started
25 Jan 2022
Ended
18 Sept 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Revascularization
  • Standard wound care
Record updated
19 December 2024
Why it stopped
High pre-screening failure and insufficient recruited patients

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Informed consent as documented by signature
  • Patients that are at least 18 years old
  • Patients that have at least one DFU(s) of ≥ 0.2 cm2 and ≤ 10 cm2 as assessed by the ruler method multiplying the greatest length and width of the ulcer after debridement to determine the surface area. The largest eligible ulcer (≤ 10 cm2) will be defined as index ulcer and the corresponding extremity as index limb (in case of multiple equally sized ulcers the following rules will apply: If on different feet, the dominant side and if on the same foot, the more peripheral one will be the index ulcer)
  • Patients that have non-critical LEAD of the index leg, defined by a single non-invasive examination at screening:; Ankle brachial index (ABI) ≥ 0.5 and ≤ 0.9 AND absolute ankle pressure ≥ 50 mmHg OR; ABI > 0.9 OR incompressible ankle pressures AND toe brachial index (TBI) ≤ 0.7 AND absolute toe pressure ≥ 30 mmHg
  • Patients on medical treatment for glycemic control with diagnosis of diabetes mellitus that was assessed by criteria as recommended by the guideline 2019 "ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD". Or patient without medical treatment but diagnosed with diabetes mellitus via HbA1c
  • Patients with life expectancy > 12 months and without any disabilities due to end-stage cancer, heart failure, severe chronic obstructive pulmonary disease (COPD), or dementia

Who cannot take part

  • Any revascularization procedure at the index leg within 3 months before randomization
  • Participation in another drug study within the 30 days preceding or during the present study
  • Severe infection at the index foot according to IDSA classification
  • Patient refuses minor amputation despite strong recommendation due to severe infection, necrosis or osteomyelitis at screening assessment
  • Non-compliance for any reason to procedures or study assessments (e.g. due to cognitive impairment or geographic distance)
  • Untreated known antiphospholipid antibody syndrome and polycythaemia vera
  • Known significant bleeding risk, or known coagulation disorder (INR > 3.0 and platelet count < 30,000/mm3) without any option to correct within 7 calendar days after initial wound assessment
  • Critical limb ischemia of the index leg defined as ABI ≤ 0.4 (or absolute ankle pressure < 50 mmHg)
  • No option to assess for toe pressure due to any reason at baseline if ABI > 0.9 or incompressible ankle pressures and patient inclusion is based on the toe pressure criteria
  • Need for major amputation
  • Positive urine or blood pregnancy test result, breast feeding or intention to become pregnant

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study investigates whether, compared to standard treatment, immediate restoration of blood flow (revascularization) can reduce complications and improve diabetic foot ulcer healing.

The 2 groups in the trial

  • Control ArmExisting treatment, for comparison

    Standard wound care for diabetic wound ulcer

    Treatment: Standard wound care

  • Immediate revascularizationTreatment being tested

    Patient will have revascularization 0 - 7 days after initial wound assessment and then receive standard wound care for diabetic wound ulcer

    Treatment: Revascularization and Standard wound care

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease: a Randomized, Controlled Trial
Record updated
19 December 2024